Longstanding barriers to care combined with an elevated risk of diabetic macular edema (DME) contribute to the disproportionate burden of DME in Native American communities.
Join us for a live webinar focused on the evolving role of immunotherapy in early-stage resectable non-small cell lung cancer (NSCLC).
Novel targeted therapies offer new hope to slow progression and improve quality of life in meaningful ways for patients with primary biliary cholangitis (PBC).
Platinum-resistant ovarian cancer (PROC) remains one of the most significant challenges in gynecologic oncology; however, novel antibody-drug conjugates (ADCs) and innovative investigational therapies are opening new avenues to improve outcomes.
Join us for a live webinar where expert faculty will provide actionable insights on improving patient identification and engagement for CAR T-cell therapy in diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL).
Join us for this live national webinar designed to bridge real-world patient perspectives with the latest advances in metastatic breast cancer (MBC) care.
Join us for a dynamic, live webinar where two leading GI oncology experts will break down the latest advancements in biomarker-based, first-line treatment strategies for upper gastrointestinal (GI) cancers.
Join us for a live, interactive TheraTalk session with an expert panel of nationally recognized lipid specialists as they review the latest guideline recommendations, pivotal evidence, and evolving strategies for LDL-C management.
Current evidence-based recommendations for prescribing diabetes medications, including newer pharmacologic classes such as glucagon-like peptide-1 receptor agonists (GLP-1r) and sodium glucose co-transporter-2 inhibitors (SGLTi) medications.
Close the technology gap and improve patient outcomes , this program provides a review of the latest diabetes technologies, including continuous glucose monitors (CGMs), insulin pumps, automated insulin delivery (AID) systems, and smart insulin pens.
